The Cashflow Memo
Capital Structure Week
Nvidia confirmed the demand picture. Three companies restructured this week to monetize it.
The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 94 companies in the Cash Flow Memo. About 13 minutes. No filler.
Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2622.
Chapter markers
0:00 | Opening disclaimer
0:15 | Cold open + the week’s throughline
0:45 | Theme — Capital structure week (NextEra, Lantheus, FedEx)
4:45 | Deep dive — Nvidia Q1 FY27
8:45 | Rapid-fire — CRM/SNOW pre-prints, Deere, BioNTech, Target/Walmart, Verizon/T-Mobile, Regeneron
11:45 | Close + Consensus Watch + forward week
12:30 | Closing disclaimer
Full transcript
Opening disclaimer
Ava: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.
Cold open
Ava: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.
Marcus: And I’m Marcus Graham — the cashflow desk.
Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. And this is still a pilot — tell us what’s landing and what isn’t.
Ava: Here’s the week. Nvidia confirmed the AI demand picture on Tuesday. And three companies in the memo restructured this week to monetize it. NextEra is buying a $67 billion utility for the power. Lantheus is in sale talks at roughly $7 billion for the radiopharma platform. And FedEx is spinning Freight on June 1. On Wednesday’s show, Hunt, Jason, and Mike walked through Google’s real AI risk — not ChatGPT, but agentic search and Gemini Spark[^ep-e2621]. Today’s show is what the rest of the universe did about it.
Theme — Capital structure week
Ava: Three restructurings in five days, three different time horizons, one read. Page 18, page 15, page 17 of the memo — all printing the same idea. The AI demand picture is now confirmed enough that companies are willing to redraw their balance sheets around it.
Ava: NextEra. $67 billion all-stock bid for Dominion Energy[^news-nee-dominion-20260523]. Combined entity becomes the world’s largest regulated utility, and management is explicit about what it’s for — they’re contracted to build 30+ data center campuses, with 15 to 30 gigawatts of generation by 2035[^news-nee-data-center-campuses-20260523]. Meta already has a 2.5 gigawatt solar-and-storage deal signed[^news-nee-meta-partnership-20260523]. Dominion stock up 9% on the announcement. NextEra down 4%[^news-nee-dominion-20260523].
Ava: Lantheus. In talks to sell to Curium at roughly $7 billion — broke Thursday[^news-lnth-curium-20260523]. This is the radiopharma roll-up everyone in oncology imaging has been waiting for. Q1 beat, PYLARIFY TruVu cleared FDA in March with a 50% batch-size lift, and the LNTH-2501 PDUFA lands June 29[^news-lnth-q1-20260523][^news-lnth-pylarify-20260523][^news-lnth-pdufa-20260523].
Ava: FedEx. Freight spins June 1 as FDXF[^news-fdx-spinoff-20260523]. Dual-market trading starts Tuesday. FedEx retains a 19.9% stake; the rest goes to holders, tax-free for U.S. federal purposes[^news-fdx-dual-market-20260523][^news-fdx-tax-20260523]. CEO Raj Subramaniam separately dismissed the Amazon-logistics-threat narrative this week[^news-fdx-amazon-20260523]. Marcus — the cashflow take. Start with the one that’s actually changing right now.
Marcus: NextEra is the one that matters this week. The memo had them at 28x trailing free cash flow at a 5% yield going in, Q1 10-Q confirmed[^memo-nee-evfcf-20260522]. That’s a clean number for a regulated utility. But the load-bearing line was already debt-to-FCF at 11x trailing[^memo-nee-debtfcf-20260522]. Now they’re eating Dominion’s leverage in an all-stock deal. The trade is: investors get the regulated-utility tail on AI infrastructure that hyperscaler multiples don’t price, and in exchange they take on a balance sheet that will look heavier before it earns through. What to watch on the next print is whether the contracted gigawatt backlog converts fast enough to absorb the debt the deal piles on.
Ava: Translation: you bought the utility because the data centers needed the power, not the chips. Lantheus?
Marcus: Lantheus is the cleanest balance sheet of the three. The memo had them at 35x trailing free cash flow at a roughly 3% yield, debt-to-FCF basically zero[^memo-lnth-evfcf-20260522][^memo-lnth-debtfcf-20260522]. $7 billion is a reasonable mark on a company with a Q1 beat, a fresh FDA approval, and a PDUFA five weeks out. The radiopharma platform is what Curium is buying — the imaging stack plus the therapeutic pipeline. Not financial engineering. Strategic consolidation in a category where the FDA pipeline is the asset.
Ava: And FedEx is the third one — different structure entirely.
Marcus: FedEx is the most interesting capital structure of the three. The memo had FDX at 22x trailing free cash flow at a roughly 6% yield, debt-to-FCF at 7.5x[^memo-fdx-evfcf-20260522][^memo-fdx-debtfcf-20260522]. The Freight spin lets the parent re-rate around the express business; the retained stake gives the holdco a forward monetization option. That’s not a tax dodge — that’s management taking the discount the market puts on the bundle and letting it trade separately.
Ava: Three balance-sheet decisions, made the same week Nvidia gave you the demand picture they’re all pricing against. Mark that.
Deep dive — Nvidia
Ava: Nvidia’s Q1 fiscal 2027 print, after the close Tuesday. The bull case got everything it asked for. The bear case got nothing it asked for.
Ava: Revenue $82 billion, up 85% year-over-year and 20% sequentially[^news-nvda-q1-rev-20260523]. Data Center alone was $75 billion — nearly double the prior-year quarter[^news-nvda-data-center-20260523]. Gross margin held at 75%, essentially flat to Q4[^news-nvda-gm-20260523]. Diluted GAAP EPS $1.87, up 140%[^news-nvda-eps-20260523].
Ava: Then they guided. Q2 revenue $91 billion, plus-or-minus 2%[^news-nvda-q2-guide-20260523]. Margin guide held at 75%[^news-nvda-margin-guide-20260523]. Blackwell 300 and the B200 line sold out through mid-2026 per management[^news-nvda-blackwell-demand-20260523]. Rubin platform confirmed for Q3 launch this year, Rubin Ultra in H2 2027[^news-nvda-rubin-20260523].
Ava: And then the capital return. They raised the dividend 25-fold — from $0.01 to $0.25 per share — and authorized an additional $80 billion of buybacks[^news-nvda-capital-allocation-20260523]. Marcus, the cashflow take.
Marcus: Nvidia just gave you the next twelve months of justification in one forward number. The memo had them at 50x trailing free cash flow at about a 2% yield going in, Q4 FY26 10-K confirmed[^memo-nvda-evfcf-20260522]. We re-anchor when the Q1 10-Q files. The $91 billion Q2 guide is what changes the read[^news-nvda-q2-guide-20260523] — that’s a single quarter of revenue close to the company’s entire trailing-twelve free cash flow base[^memo-nvda-fcf-20260522]. The multiple was never the problem here. The problem was always whether the Q2 guide would hold the rate of change. It did.
Ava: One sentence on why the dividend matters.
Marcus: It signals that Jensen Huang now believes the cash generation is structural, not cyclical. You don’t 25x the dividend on a company you think is at the top. The $80 billion buyback authorization is the second signal — they’re going to be in the open market accumulating their own equity while the next product cycle ramps. The question for the next print isn’t whether the demand is real. The question is whether anything in the Blackwell-to-Rubin transition slips, because at this multiple, any timing miss is the entire risk.
Ava: And the consensus narrative on the print?
Marcus: Wall Street had a version of the law of large numbers eats Nvidia by 2027. The Q2 $91 billion guide just told you the law of large numbers gets eaten first. Bear modelers said this rate of change couldn’t continue at this base. They were wrong, and they’re going to be wrong again next quarter unless something physical breaks in the supply chain.
Ava: So the bear case now has to argue physics, not math. Two prints from now, mark the calendar.
Rapid-fire
Ava: Five forward-week catalysts and one governance shock to close. Buckle up.
Ava: Page 2 of the memo — Salesforce and Snowflake both report after the close Tuesday[^earn-crm][^earn-snow]. Consensus on Salesforce: $3.12 EPS, $11 billion revenue[^earn-crm]. Consensus on Snowflake: $0.32, $1.3 billion[^earn-snow]. The Salesforce setup has CEO Marc Benioff committing $300 million of Anthropic token spend for the year, with AI coding agents delivering 30% engineering productivity gains and no incremental engineering hires[^news-crm-benioff-anthropic-20260523]. And per Talnexis hiring data, Salesforce’s AI/ML postings spiked 5.6x in the last 7 days — 28 new roles versus 5 the week prior — heading straight into the print[^tlnx-crm-aiml-20260523]. Memo had Salesforce at 28x trailing free cash flow going in, Q4 10-K confirmed[^memo-crm-evfcf-20260522]. Re-anchor Wednesday morning.
Ava: Snowflake is the harder one. Memo can’t anchor on a multiple — trailing free cash flow runs negative, capex still scaling against the AI workload ramp[^memo-snow-fcf-20260522]. What prices Snowflake right now is Cortex AI adoption — 9,100 customer accounts, 200%+ YoY AI-workload growth, NRR holding at 125%, RPO accelerating 42% year-over-year[^news-snow-cortex-20260523][^news-snow-nrr-20260523]. And the Talnexis hiring tracker shows Snowflake’s Partnerships postings up 5.5x in 7 days — 11 new partnerships roles versus 2 the week prior[^tlnx-snow-partnerships-20260523]. The pre-print read: the ecosystem-monetization push is hiring like it’s a real business.
Ava: Deere reported Wednesday. EPS $6.55 against $5.74 consensus, a 14% beat[^news-de-q2-earnings-20260521]. But the composition is the story. Construction and Forestry revenue up 29%, op profit up 48%[^news-de-construction-20260521]. Production and Precision Ag revenue down 14%, op profit down 39%[^news-de-ag-decline-20260521]. And $272 million of the beat came from a Supreme Court IEEPA tariff recovery[^news-de-tariff-20260521]. Strip that out, the print is in-line at best. Construction is booming, farmers are buying nothing, and the tariff lawyers paid the difference.
Ava: BioNTech. Q1 loss of €531.9 million — and the company is buying back €1 billion of stock into it[^news-bntx-q1-loss-20260523]. What they’re spending on is BNT327, their lead bispecific antibody. Phase 2 small-cell lung cancer just printed 16.8 months median overall survival[^news-bntx-bnt327-survival-20260523]. Phase 3 push is on, with combination trials running across non-small-cell lung, triple-negative breast, and pancreatic[^news-bntx-bnt327-combos-20260523]. The loss is real. The platform bet is what’s getting funded.
Ava: Page 8 — Target and Walmart, same week, opposite reads. Target beat on Q1 comps up 5.6% — their first positive comp in five quarters — and raised the full-year guide[^news-tgt-q1-20260523][^news-tgt-guidance-20260523]. Walmart printed strong e-commerce growth — 26% globally, marketplace up nearly 50% — and the stock fell 7% on a cautious full-year guide[^news-wmt-ecom-20260523][^news-wmt-earnings-20260523]. Same consumer. Same week. Two different reads on what Walmart’s franchise actually sees ahead of it.
Ava: Page 6 — both wireless carrier CEO chairs moved this week. Dan Schulman in at Verizon, Hans Vestberg to Special Advisor through October[^news-vz-ceo-20260523]. Srini Gopalan in at T-Mobile in six weeks, Mike Sievert to vice chairman[^news-tmus-ceo-20260523]. And the same week — Verizon, AT&T, and T-Mobile announced a three-way joint venture on direct-to-device satellite to compete with Starlink, while T-Mobile separately launched SuperBroadband with Starlink at $250 a month[^news-tmus-jv-20260523][^news-tmus-starlink-20260523]. Read into the timing what you will.
Ava: And Regeneron — fianlimab-plus-Libtayo missed primary endpoint in the 1,546-patient melanoma Phase 3, lost head-to-head to Keytruda, stock down 10.5% on the news[^news-regn-melanoma-20260523]. The Eylea HD extended-dosing approval and Dupixent’s 33% Q1 growth are still there[^news-regn-eylea-20260523][^news-regn-dupixent-20260523]. But the oncology pipeline just took a real hit.
Close
Ava: That’s the show. Wall Street’s consensus on the week: Nvidia was priced for perfection going in, and the print was the test. They were half right. It was priced for perfection. It also delivered perfection. The next test is whether Salesforce and Snowflake confirm the Agentforce and Cortex traction Tuesday afternoon.
Ava: Hiring data this week from Talnexis — talnexis.com.
Ava: Forward week — Salesforce and Snowflake Tuesday after the close, Costco Wednesday, Broadcom and Five Below on June 3. Hunt, Jason, and Mike are back Wednesday on episode 2622 — Hunt teased a surprise topic in place of the usual healthcare slot[^ep-e2621]. Get the Cash Flow Memo at telltales.us.
Closing disclaimer
Ava: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.
Sources
BioNTech Investor Relations. (2026, May). BioNTech clinical data at ELCC 2026 highlight potential of differentiated late-stage portfolio in lung cancer [Press release]. https://investors.biontech.de/news-releases/news-release-details/biontech-clinical-data-elcc-2026-highlight-potential
Fierce Biotech. (2026, May). BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific. https://www.fiercebiotech.com/biotech/biontech-shows-lung-cancer-survival-data-behind-phase-3-push-red-hot-bispecific
Canary Media. (2026, May 18). NextEra Energy wants to buy its way into Data Center Alley. https://www.canarymedia.com/articles/utilities/nextera-energy-wants-to-buy-its-way-into-data-center-alley
Carbon Credits. (2026, May). Meta and NextEra partner for a big solar and storage energy deal. https://carboncredits.com/meta-and-nextera-partner-for-a-big-solar-and-storage-energy-deal/
CNBC. (2026, May 12). FedEx CEO brushes off Amazon’s new logistics service that recently sent shares tumbling. https://www.cnbc.com/2026/05/12/fed-ex-ceo-jim-cramer-amazon-logistics.html
CNBC. (2026, May 18). NextEra Energy (NEE) to buy Dominion Energy (D). https://www.cnbc.com/2026/05/18/nextera-nee-dominion-energy-d-data-center-ai.html
CNBC. (2026, May 18). Regeneron drops after skin cancer treatment misses late-stage trial goal. https://www.cnbc.com/2026/05/18/regeneron-drops-after-skin-cancer-treatment-misses-late-stage-trial-goal.html
CNBC. (2026, May 20). Nvidia (NVDA) earnings report Q1 2027. https://www.cnbc.com/2026/05/20/nvidia-nvda-earnings-report-q1-2027.html
CNBC. (2026, May 21). Walmart issues worse-than-expected outlook as high gas prices hit shoppers, shares drop 7%. https://www.cnbc.com/2026/05/21/walmart-wmt-earnings-q1-2027.html
Eyewire+. (2026). Regeneron secures FDA approval to extend Eylea HD dosing intervals to up to 20 weeks. https://eyewire.news/news/regeneron-secures-fda-approval-to-extend-eylea-hd-dosing-intervals-to-up-to-20-weeks
FedEx Investor News. (2026, May 13). FedEx board of directors approves spin-off of FedEx Freight [Press release]. https://investors.fedex.com/news-and-events/investor-news/investor-news-details/2026/FedEx-Board-of-Directors-Approves-Spin-off-of-FedEx-Freight/default.aspx
Financial Content. (2025, December 29). Nvidia’s Blackwell dynasty: B200 and GB200 sold out through mid-2026 as backlog hits 3.6 million units. https://markets.financialcontent.com/wral/article/tokenring-2025-12-29-nvidias-blackwell-dynasty-b200-and-gb200-sold-out-through-mid-2026-as-backlog-hits-3-6-million-units
GeekWire. (2026, May 23). T-Mobile enlists Starlink satellites for new SuperBroadband business internet service. https://www.geekwire.com/2026/t-mobile-enlists-starlink-satellites-for-new-superbroadband-business-internet-service/
Investing.com. (2026, April 29). Regeneron beats first quarter estimates on Dupixent strength. https://www.investing.com/news/earnings/regeneron-beats-first-quarter-estimates-on-dupixent-strength-4644258
Lantheus Holdings. (2026, March 6). Lantheus announces FDA approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection [Press release]. https://investor.lantheus.com/news-releases/news-release-details/lantheus-announces-fda-approval-pylarify-truvutm-piflufolastat-f
Lantheus Holdings. (2026, May 7). Form 10-Q FY2026 [SEC filing]. https://www.sec.gov/Archives/edgar/data/0001521036/000119312526210373/lnth-20260331.htm
Lopez, M. (2026, May 22). Lantheus (LNTH) weighs potential $7 billion sale following offer from Curium. Bloomberg. https://www.bloomberg.com/news/articles/2026-05-22/lantheus-is-said-to-weigh-sale-following-offer-from-curium
MarketBeat. (2026, May 20). NVIDIA Corp. Q1 FY2027 earnings report. https://www.marketbeat.com/earnings/reports/2026-5-20-nvidia-co-stock/
MarketBeat. (2026, May 21). Deere & Company Q2 2026 earnings report. https://www.marketbeat.com/earnings/reports/2026-5-21-deere-company-stock/
Morningstar. (2026, May 12). FedEx board of directors approves spin-off of FedEx Freight. https://www.morningstar.com/news/business-wire/20260512056825/fedex-board-of-directors-approves-spin-off-of-fedex-freight
NVIDIA Newsroom. (n.d.). Rubin platform AI supercomputer [Press release]. https://nvidianews.nvidia.com/news/rubin-platform-ai-supercomputer
Quartz. (2026, May 20). Target Q1 2026 earnings beat: Sales surge, outlook raised. https://qz.com/target-earnings-sales-growth-full-year-outlook-052026
Quiver Quantitative. (2026, May 7). Lantheus Holdings ($LNTH) releases Q1 2026 earnings. https://www.quiverquant.com/news/LANTHEUS+HOLDINGS+%28%24LNTH%29+Releases+Q1+2026+Earnings
Salesforce. (n.d.). Marc Benioff says Salesforce will spend $300M on Anthropic in 2026. Yahoo Finance. https://finance.yahoo.com/sectors/technology/articles/marc-benioff-says-salesforce-spend-133651072.html
Simply Wall St. (2026, May 23). Assessing BioNTech (BNTX) valuation after prolonged share price weakness and loss-making results. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bntx/biontech/news/assessing-biontech-bntx-valuation-after-prolonged-share-pric
Snowflake. (n.d.). Snowflake Inc. Q4 FY2026 earnings 8-K [SEC filing]. https://www.sec.gov/Archives/edgar/data/0001640147/000162828026011631/fy2026q4earnings.htm
StockInvest.us. (n.d.). Snowflake earnings report: Key numbers & transcript summary. https://stockinvest.us/earnings-report/SNOW
Target Corporate. (2026, May 20). Target Q1 2026 earnings highlights [Press release]. https://corporate.target.com/news-features/article/2026/05/q1-2026-earnings
Telecoms.com. (2026, May 23). Gopalan to replace Sievert as T-Mobile US CEO in six weeks. https://www.telecoms.com/operator-ecosystem/gopalan-to-replace-sievert-as-t-mobile-us-ceo-in-six-weeks/
Teslarati. (2026, May 23). SpaceX just forced Verizon, AT&T and T-Mobile to team up for the first time in history. https://www.teslarati.com/spacex-starlink-vs-verizon-att-tmobile-d2d-direct-device/
Verizon. (n.d.). Verizon announces CEO transition [Press release]. https://www.verizon.com/about/news/verizon-announces-ceo-transition
Walmart Inc. (2026, May 21). Form 8-K — earnings release FY27 Q1 [SEC filing]. https://www.sec.gov/Archives/edgar/data/0000104169/000010416926000095/earningspresentationfy27.htm
Yahoo Finance. (2026, May 21). Deere & Co (DE) Q2 2026 earnings call highlights: Strong sales growth amidst challenges. https://finance.yahoo.com/markets/stocks/articles/deere-co-q2-2026-earnings-230050659.html
24/7 Wall St. (2026, May 21). Deere (DE) Q2 2026 earnings call transcript. https://247wallst.com/companies/de/earnings/
Internal data
Internal data is provided on a best efforts basis.
Hiring intelligence data
Hiring data this week from Talnexis — talnexis.com. Talnexis tracks 98 top tech companies and refreshes hiring intelligence daily from public job boards.
CRM — Salesforce: AI_HIRING_SURGE on AI/ML postings (28 roles in 7d vs 5 prior, 5.6x). Detected 2026-05-23. Source: https://www.talnexis.com/
SNOW — Snowflake: CATEGORY_SPIKE on Partnerships postings (11 roles in 7d vs 2 prior, 5.5x). Detected 2026-05-23. Source: https://www.talnexis.com/
Earnings calendar
Source: FMP /api/v3/earning_calendar, pulled 2026-05-23. Filtered to the 94-ticker Cashflow Memo universe.
CRM — Salesforce: 2026-05-27 AMC. Consensus EPS $3.12, revenue $11.05B
SNOW — Snowflake: 2026-05-27 AMC. Consensus EPS $0.32, revenue $1.32B
COST — Costco: 2026-05-28. Consensus EPS $4.98, revenue $69.61B
AVGO — Broadcom: 2026-06-03. Consensus EPS $2.40, revenue $22.04B
FIVE — Five Below: 2026-06-03. Consensus EPS $1.71, revenue $1.21B








